欧林生物(688319.SH)：上半年净利润1319.69万元 同比扭亏为盈

Group 1 - The core viewpoint of the article is that Olin Bio (688319.SH) has reported significant growth in its financial performance for the first half of 2025, indicating a positive turnaround for the company [1] - The company achieved an operating revenue of 305.85 million yuan, representing a year-on-year increase of 35.17% [1] - The net profit attributable to shareholders of the listed company was 13.20 million yuan, marking a return to profitability compared to the previous period [1]